Tokyo Tape
Sign in
← baby calendar

Annual report

7363.TEDINET S100VJ10
Period2024-01-01 → 2024-12-31
Filed2025-03-31
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed

Amended by S100YNO5 (2026-06-30).

Key figures · 85
MetricValuePeriodScopeSource row
Revenue¥1.5bn2024-01-01 → 2024-12-31StandaloneNet sales
Revenue¥1.2bn2023-01-01 → 2023-12-31StandaloneNet sales
Revenue¥1.1bn2022-01-01 → 2022-12-31dStandaloneNet sales (5-year summary)
Revenue¥1.0bn2021-01-01 → 2021-12-31dStandaloneNet sales (5-year summary)
Revenue¥894m2020-01-01 → 2020-12-31dStandaloneNet sales (5-year summary)
Operating income¥50m2024-01-01 → 2024-12-31StandaloneOperating income
Operating income−¥31m2023-01-01 → 2023-12-31StandaloneOperating income
Ordinary income¥48m2024-01-01 → 2024-12-31StandaloneOrdinary income
Ordinary income−¥27m2023-01-01 → 2023-12-31StandaloneOrdinary income
Ordinary income¥37m2022-01-01 → 2022-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥116m2021-01-01 → 2021-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥96m2020-01-01 → 2020-12-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax−¥343,0002024-01-01 → 2024-12-31StandaloneIncome before income taxes
Profit before tax−¥45m2023-01-01 → 2023-12-31StandaloneIncome before income taxes
Net income¥17m2024-01-01 → 2024-12-31StandaloneProfit loss
Net income−¥100m2023-01-01 → 2023-12-31StandaloneProfit loss
Net income¥21m2022-01-01 → 2022-12-31dStandaloneNet income loss (5-year summary)
Net income¥75m2021-01-01 → 2021-12-31dStandaloneNet income loss (5-year summary)
Net income¥62m2020-01-01 → 2020-12-31dStandaloneNet income loss (5-year summary)
Total assets¥1.6bnat 2024-12-31StandaloneAssets
Total assets¥1.0bnat 2023-12-31StandaloneAssets
Total assets¥1.1bnat 2022-12-31dStandaloneTotal assets (5-year summary)
Total assets¥1.4bnat 2021-12-31dStandaloneTotal assets (5-year summary)
Total assets¥502mat 2020-12-31dStandaloneTotal assets (5-year summary)
Total liabilities¥854mat 2024-12-31StandaloneLiabilities
Total liabilities¥315mat 2023-12-31StandaloneLiabilities
Net assets / equity¥705mat 2024-12-31StandaloneNet assets
Net assets / equity¥706mat 2023-12-31StandaloneNet assets
Net assets / equity¥806mat 2022-12-31dStandaloneNet assets
Net assets / equity¥872mat 2021-12-31dStandaloneNet assets (5-year summary)
Net assets / equity¥346mat 2020-12-31dStandaloneNet assets (5-year summary)
Cash and deposits¥394mat 2024-12-31StandaloneCash and deposits
Cash and deposits¥357mat 2023-12-31StandaloneCash and deposits
Cash & equivalents¥394mat 2024-12-31StandaloneCash and cash equivalents
Cash & equivalents¥357mat 2023-12-31StandaloneCash and cash equivalents
Cash & equivalents¥716mat 2022-12-31dStandaloneCash and cash equivalents
Cash & equivalents¥1.0bnat 2021-12-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥237mat 2020-12-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow¥195m2024-01-01 → 2024-12-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥14m2023-01-01 → 2023-12-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥3m2022-01-01 → 2022-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥96m2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥148m2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥599m2024-01-01 → 2024-12-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥290m2023-01-01 → 2023-12-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥134m2022-01-01 → 2022-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥17m2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥78m2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow¥285m2024-01-01 → 2024-12-31StandaloneNet cash provided by used in financing activities
Financing cash flow−¥55m2023-01-01 → 2023-12-31StandaloneNet cash provided by used in financing activities
Financing cash flow−¥189m2022-01-01 → 2022-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥726m2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥17m2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥19.422024-01-01 → 2024-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-111.172023-01-01 → 2023-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥22.942022-01-01 → 2022-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥87.662021-01-01 → 2021-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥83.392020-01-01 → 2020-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥19.132024-01-01 → 2024-12-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥22.42022-01-01 → 2022-12-31dStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥78.912021-01-01 → 2021-12-31dStandaloneDiluted earnings per share (5-year summary)
Net assets per share¥790.97at 2024-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥783.42at 2023-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥893.39at 2022-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥955.38at 2021-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥465.52at 2020-12-31dStandaloneNet assets per share (5-year summary)
Equity ratio45.2%at 2024-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio69.2%at 2023-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio71.3%at 2022-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio64.2%at 2021-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio68.8%at 2020-12-31dStandaloneEquity to asset ratio (5-year summary)
ROE2.4%2024-01-01 → 2024-12-31StandaloneRate of return on equity (5-year summary)
ROE2.5%2022-01-01 → 2022-12-31dStandaloneRate of return on equity (5-year summary)
ROE12.3%2021-01-01 → 2021-12-31dStandaloneRate of return on equity (5-year summary)
ROE19.6%2020-01-01 → 2020-12-31dStandaloneRate of return on equity (5-year summary)
Shares issued941,700at 2024-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued941,700at 2023-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued941,700at 2022-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued912,200at 2021-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued743,000at 2020-12-31dStandaloneTotal number of issued shares (5-year summary)
Employees74at 2024-12-31StandaloneNumber of employees
Employees71at 2023-12-31StandaloneNumber of employees
Employees56at 2022-12-31dStandaloneNumber of employees
Employees49at 2021-12-31dStandaloneNumber of employees
Employees45at 2020-12-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 38
SegmentItemPeriodValue
Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segmentcapex2024-01-01 → 2024-12-31¥6m
Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segmentdepreciation2024-01-01 → 2024-12-31¥4m
Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segmentemployeesat 2024-12-3120 pure
Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segmentrevenue2024-01-01 → 2024-12-31¥283m
Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segmentrevenue external2024-01-01 → 2024-12-31¥283m
Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segmentsegment assetsat 2024-12-31¥75m
Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segmentsegment profit2024-01-01 → 2024-12-31−¥4m
Media Business For Pregnancy Childbirth And Childcarereportable segmentcapex2024-01-01 → 2024-12-31¥503m
Media Business For Pregnancy Childbirth And Childcarereportable segmentdepreciation2024-01-01 → 2024-12-31¥62m
Media Business For Pregnancy Childbirth And Childcarereportable segmentemployeesat 2024-12-3147 pure
Media Business For Pregnancy Childbirth And Childcarereportable segmentrevenue2024-01-01 → 2024-12-31¥1.2bn
Media Business For Pregnancy Childbirth And Childcarereportable segmentrevenue external2024-01-01 → 2024-12-31¥1.2bn
Media Business For Pregnancy Childbirth And Childcarereportable segmentsegment assetsat 2024-12-31¥980m
Media Business For Pregnancy Childbirth And Childcarereportable segmentsegment profit2024-01-01 → 2024-12-31¥347m
Total Of Reportable Segments And Otherssegment totalcapex2024-01-01 → 2024-12-31¥509m
Total Of Reportable Segments And Otherssegment totaldepreciation2024-01-01 → 2024-12-31¥66m
Total Of Reportable Segments And Otherssegment totalrevenue2024-01-01 → 2024-12-31¥1.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2024-01-01 → 2024-12-31¥1.5bn
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2024-12-31¥1.1bn
Total Of Reportable Segments And Otherssegment totalsegment profit2024-01-01 → 2024-12-31¥343m
Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segmentcapex2023-01-01 → 2023-12-31¥3m
Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segmentdepreciation2023-01-01 → 2023-12-31¥7m
Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segmentrevenue2023-01-01 → 2023-12-31¥299m
Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segmentrevenue external2023-01-01 → 2023-12-31¥299m
Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segmentsegment assetsat 2023-12-31¥69m
Developing Management Support Solution Business For Obstetrics And Gynecologyreportable segmentsegment profit2023-01-01 → 2023-12-31¥17m
Media Business For Pregnancy Childbirth And Childcarereportable segmentcapex2023-01-01 → 2023-12-31¥167m
Media Business For Pregnancy Childbirth And Childcarereportable segmentdepreciation2023-01-01 → 2023-12-31¥33m
Media Business For Pregnancy Childbirth And Childcarereportable segmentrevenue2023-01-01 → 2023-12-31¥904m
Media Business For Pregnancy Childbirth And Childcarereportable segmentrevenue external2023-01-01 → 2023-12-31¥904m
Media Business For Pregnancy Childbirth And Childcarereportable segmentsegment assetsat 2023-12-31¥393m
Media Business For Pregnancy Childbirth And Childcarereportable segmentsegment profit2023-01-01 → 2023-12-31¥197m
Total Of Reportable Segments And Otherssegment totalcapex2023-01-01 → 2023-12-31¥170m
Total Of Reportable Segments And Otherssegment totaldepreciation2023-01-01 → 2023-12-31¥40m
Total Of Reportable Segments And Otherssegment totalrevenue2023-01-01 → 2023-12-31¥1.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-01-01 → 2023-12-31¥1.2bn
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2023-12-31¥463m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-01-01 → 2023-12-31¥214m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 872
ItemContextValueUnit
Governance (text)FilingDateInstantText · Plus
Strategy (text)FilingDateInstantText · Plus
Policy on development of human resources and internal environment strategy (text)FilingDateInstantText · Plus
Risk management (text)FilingDateInstantText · Plus
Metrics and targets (text)FilingDateInstantText · Plus
Description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics metrics and targets (text)FilingDateInstantText · Plus
Business risks (text)FilingDateInstantText · Plus
Management analysis of financial position operating results and cash flows (text)FilingDateInstantText · Plus
Critical contracts for operation (text)FilingDateInstantText · Plus
Research and development activities (text)FilingDateInstantText · Plus
Overview of capital expenditures etc (text)FilingDateInstantText · Plus
Major facilities (text)FilingDateInstantText · Plus
Planned additions retirements etc of facilities (text)FilingDateInstantText · Plus
Total number of shares (text)FilingDateInstantText · Plus
Issued shares total number of shares etc (text)FilingDateInstantText · Plus
Class issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember
Original text (Japanese)普通株式
Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registeredFilingDateInstant_OrdinaryShareMember
Original text (Japanese)東京証券取引所(グロース)
Description issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember
Original text (Japanese)権利内容に何ら限定のない当社における標準となる株式であり、単元株式数は100株であります。
Details of employee share option program (text)FilingDateInstantText · Plus
Description of rights plan (text)FilingDateInstantText · Plus
Other information on share acquisition rights (text)FilingDateInstantText · Plus
Exercises etc of moving strike convertible bonds etc (text)FilingDateInstantText · Plus
Changes in number of issued shares stated capital etc (text)FilingDateInstantText · Plus
Shareholding by shareholder category (text)FilingDateInstantText · Plus
Major shareholders (text)FilingDateInstantText · Plus
Name major shareholdersCurrentYearInstant_No1MajorShareholdersMember
Original text (Japanese)安田　啓司
Address major shareholdersCurrentYearInstant_No1MajorShareholdersMember
Original text (Japanese)東京都稲城市
Name major shareholdersCurrentYearInstant_No2MajorShareholdersMember
Original text (Japanese)山田　育代
Address major shareholdersCurrentYearInstant_No2MajorShareholdersMember
Original text (Japanese)静岡県熱海市
Name major shareholdersCurrentYearInstant_No3MajorShareholdersMember
Original text (Japanese)森　帆久
Address major shareholdersCurrentYearInstant_No3MajorShareholdersMember
Original text (Japanese)東京都中央区
Name major shareholdersCurrentYearInstant_No4MajorShareholdersMember
Original text (Japanese)ＡＳＧＪａｐａｎ株式会社
Address major shareholdersCurrentYearInstant_No4MajorShareholdersMember
Original text (Japanese)東京都千代田区内幸町１丁目１番１号
Name major shareholdersCurrentYearInstant_No5MajorShareholdersMember
Original text (Japanese)福島　智晴
Address major shareholdersCurrentYearInstant_No5MajorShareholdersMember
Original text (Japanese)神奈川県横浜市中区
Name major shareholdersCurrentYearInstant_No6MajorShareholdersMember
Original text (Japanese)株式会社ステムセル研究所
Address major shareholdersCurrentYearInstant_No6MajorShareholdersMember
Original text (Japanese)東京都港区虎ノ門１丁目21番19号
Name major shareholdersCurrentYearInstant_No7MajorShareholdersMember
Original text (Japanese)オオサキメディカル株式会社
Address major shareholdersCurrentYearInstant_No7MajorShareholdersMember
Original text (Japanese)愛知県名古屋市西区玉池町203番地
Name major shareholdersCurrentYearInstant_No8MajorShareholdersMember
Original text (Japanese)株式会社ＳＢＩ証券
Address major shareholdersCurrentYearInstant_No8MajorShareholdersMember
Original text (Japanese)東京都港区六本木１丁目６番１号
Name major shareholdersCurrentYearInstant_No9MajorShareholdersMember
Original text (Japanese)藤盛　良平
Address major shareholdersCurrentYearInstant_No9MajorShareholdersMember
Original text (Japanese)東京都文京区
Name major shareholdersCurrentYearInstant_No10MajorShareholdersMember
Original text (Japanese)大崎　将男
Address major shareholdersCurrentYearInstant_No10MajorShareholdersMember
Original text (Japanese)愛知県名古屋市西区
Issued shares voting rights (text)FilingDateInstantText · Plus
Description issued shares voting rightsCurrentYearInstant_SharesWithNoVotingRightsMember－
Description issued shares voting rightsCurrentYearInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember－
Description issued shares voting rightsCurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember－
Description issued shares voting rightsCurrentYearInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember－

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 13 of 13 passed
balance sheet identitynon_consolidated 2023-12-31pass rounding
balance sheet identitynon_consolidated 2024-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · net assetsnon_consolidated 2023-12-31pass
statement vs summary · net assetsnon_consolidated 2024-12-31pass
statement vs summary · operating cash flownon_consolidated 2023-01-01/2023-12-31pass
statement vs summary · operating cash flownon_consolidated 2024-01-01/2024-12-31pass
statement vs summary · revenuenon_consolidated 2023-01-01/2023-12-31pass
statement vs summary · revenuenon_consolidated 2024-01-01/2024-12-31pass
statement vs summary · total assetsnon_consolidated 2023-12-31pass
statement vs summary · total assetsnon_consolidated 2024-12-31pass